Daiwa Securities Group’s Xenon Pharmaceuticals XENE Stock Holding History

Daiwa Securities Group’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-229	Closed	-$10K	–	1453
2025 Q4	$10K	Sell	229 -23	-9%	-$966	﹤0.01%	1188
2025 Q3	$10K	Hold	252	–	–	﹤0.01%	1160
2025 Q2	$8K	Hold	252	–	–	﹤0.01%	1128
2025 Q1	$8K	Hold	252	–	–	﹤0.01%	1109
2024 Q4	$10K	Sell	252 -36	-13%	-$1.49K	﹤0.01%	1123
2024 Q3	$11K	Buy	288 +36	+14%	+$1.45K	﹤0.01%	1126
2024 Q2	$10K	Hold	252	–	–	﹤0.01%	1164
2024 Q1	$11K	Hold	252	–	–	﹤0.01%	1164
2023 Q4	$12K	Hold	252	–	–	﹤0.01%	1162
2023 Q3	$9K	Hold	252	–	–	﹤0.01%	1134
2023 Q2	$10K	Hold	252	–	–	﹤0.01%	1140
2023 Q1	$9K	Hold	252	–	–	﹤0.01%	1117
2022 Q4	$10K	Buy	252 +54	+27%	+$1.97K	﹤0.01%	1116
2022 Q3	$7K	Hold	198	–	–	﹤0.01%	1149
2022 Q2	$6K	Buy	198 +57	+40%	+$1.72K	﹤0.01%	1162
2022 Q1	$4K	Hold	141	–	–	﹤0.01%	1201
2021 Q4	$4K	Hold	141	–	–	﹤0.01%	1231
2021 Q3	$2K	Buy	141 +75	+114%	+$1.3K	﹤0.01%	1250
2021 Q2	$1K	Hold	66	–	–	﹤0.01%	1222
2021 Q1	$1K	Hold	66	–	–	﹤0.01%	1234
2020 Q4	$1K	Buy	+66	New	+$772	﹤0.01%	1213
2019 Q4	–	Sell	-165	Closed	-$1K	–	1253
2019 Q3	$1K	Hold	165	–	–	﹤0.01%	1163
2019 Q2	$2K	Hold	165	–	–	﹤0.01%	1155
2019 Q1	$2K	Buy	+165	New	+$1.4K	﹤0.01%	1142

Other funds holding XENE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Daiwa Securities Group's XENE Position: Q1 2026 in Review

Daiwa Securities Group sold out of Xenon Pharmaceuticals (XENE) in Q1 2026, closing a stake of 229 shares — an estimated $10K sold.

Daiwa Securities Group first reported a position in XENE in Q1 2019 and held it in 24 quarters. The position peaked at $12K in Q4 2023. 290 funds tracked by Wall St. Rank hold XENE as of Q1 2026.

Daiwa Securities Group reported no remaining Xenon Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Daiwa Securities Group sold 229 Xenon Pharmaceuticals shares in Q1 2026, an estimated $10K.
Daiwa Securities Group first reported a position in Xenon Pharmaceuticals in Q1 2019 and held it in 24 quarters.
Daiwa Securities Group's Xenon Pharmaceuticals position peaked at $12K in Q4 2023.
290 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.